Clinical Trial Update: QLS5132 Combination Therapy in Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This update describes a Phase 1/2 study of QLS5132 combination therapy in multiple cancers, including gastric cancer, non-small cell lung cancer, endometrial ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Gastric Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Solid Tumors

Drugs mentioned

• QLS5132

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Gastric Cancer (GC), Non-small Cell Lung Cancer (NSCLC) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING